Wells Fargo & Company : The sellers are gaining the upper hand
Entry price | Target | Stop-loss | Potential |
---|
US$48.51 |
US$44.4 |
US$50.7 |
+8.46% |
---|
Shares in Wells Fargo show a deteriorated chart pattern with the risk of a trend reversal. A phase of declining share prices seems to establish itself.
Strengths● The group's activity appears highly profitable thanks to its outperforming net margins.
● There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
● The company's attractive earnings multiples are brought to light by a P/E ratio at 9.93 for the current year.
● The company is one of the best yield companies with high dividend expectations.
Weaknesses● As estimated by analysts, this group is among those businesses with the lowest growth prospects.
● The company's earnings releases usually do not meet expectations.
● The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
● The underlying tendency is negative on the weekly chart below the resistance at 51.25 USD
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.